Solventum Removes Drinking-Water Unit From Thermo Fisher's Planned Filtration Buy

Published: 2025-06-25 17:20:19 ET SOLV

Published on 06/25/2025 at 17:20

By Katherine Hamilton

Thermo Fisher Scientific will no longer include Solventum's drinking water filtration business in its plan to acquire the medical-device company's filtration and purification segment.

The revised acquisition deal reduces the cash consideration to $4 billion, down from the original $4.1 billion deal that was first announced in February.

Thermo Fisher will be entitled to receive up to $75 million from Solventum upon a sale of the water business or after an agreed-upon three-year period.

Solventum said removing the water filtration business would make the deal less complicated and speed up the timeline for closing the transaction, which was previously scheduled to happen by the end of 2025.

It also creates future value opportunities from the water business, Solventum said. It will increase Solventum's annual earnings per share accretion, but will reduce the previously projected improvements in gross margin and operating margins. Solventum plans to update estimates for those figures during its second-quarter earnings call, which is scheduled for August.

Write to Katherine Hamilton at [email protected]

(END) Dow Jones Newswires

06-25-25 1719ET